Markus Puhlmann
Directeur Technique/Scientifique/R&D chez PERSPECTIVE THERAPEUTICS, INC.
Fortune : 2 M $ au 30/04/2024
Postes actifs de Markus Puhlmann
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PERSPECTIVE THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - | - |
Historique de carrière de Markus Puhlmann
Anciens postes connus de Markus Puhlmann
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SEAGEN INC. | Corporate Officer/Principal | 01/01/2019 | 01/01/2022 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2015 | 01/01/2019 |
Formation de Markus Puhlmann
| Ludwig-Maximilians-Universität München | Doctorate Degree |
| McDonough School of Business | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 4 |
| 2 | |
| Allemagne | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Consumer Services | 3 |
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
| Perspective Therapeutics, Inc. | |
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
- Bourse
- Insiders
- Markus Puhlmann
- Expérience